1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Top 6 Trends Affecting the Diagnostics Market 

Top 6 Trends Affecting the Diagnostics Market 

  • August 2015
  • -
  • Frost & Sullivan
  • -
  • 74 pages

Top 6 Trends Affecting the Diagnostics Market : Evolving Strategies by Market Leaders to Keep Up With Changing Healthcare Trends

The IVD market constantly changing. Mega Trends such as consolidation, automation, and reimbursement policies affect every aspect of the market. This study looks at the effects of these trends on three global consumer segments: hospitals, laboratories, and patients. The growing importance of diagnostics in patient care is expanding beyond hospitals and laboratories to homes, long term and chronic care, and other segments in healthcare. Apart from the major trends in IVD, there are other key trends like the growing digitalization of healthcare to enable a more efficient patient care continuum.

Key Trends in the In Vitro Diagnostics Market

Changing IVD Regulations Worldwide

Stricter US Food and Drug Administration (FDA) regulations in the US impede innovation and adoption of devices and tests in this region. Europe, even though more lenient on the regulation front, is impeded by strict reimbursement policies. Lenient policies and reimbursement breaks make China, South America, and Africa attractive for companies to launch new products.

Shift to Data Driven Healthcare

Increasing integration of digital devices is changing the face of healthcare. Technology ranges from simple automation systems in labs to Electronic Health Records (EHRs) utilizing Big Data to deliver personalized medicine.

Table Of Contents

Top 6 Trends Affecting the Diagnostics Market 
Table Of Contents
1 TOP 6 TRENDS AFFECTING THE DIAGNOSTICS MARKET

Executive Summary
1 Key Trends in the In Vitro Diagnostics Market
2 Key Trends in the In Vitro Diagnostics Market
3 The Story—Key Takeaways
4 The Story—Key Takeaways
5 Executive Summary—3 Big Predictions
6 CEO's Perspective
7 Diagnostics in Patient Care
8 Diagnostics in Patient Care
9 Diagnostics and Testing Environment
10 IVD Market Overview—Segments
11 IVD Market—Segment Overview

Trend 1—Changing Reimbursement and Regulations
1 Regulatory Policies Across the World
2 Regulatory Benchmarking—Regional analysis
3 Regulatory Benchmarking—Regional analysis
4 Regulatory Benchmarking—Regional analysis
5 A Snapshot of the Competitive Market in Hotspots

Overview of Regulations and Reimbursement in the US
1 IVD Regulations and Their Impact on Different Sectors—US
2 IVD Regulations and Their Impact on Different Sectors—US
3 Effect of New Regulations on Laboratories in the US
4 Pricing for New Tests—Market-based Pricing System
5 Pricing for New Tests
6 Retooling for the Future—Hospitals
7 Consolidation Case Study—Tenet-Vangaurd Acquisition
8 Bundled Payment Case Study—Blue Cross Blue Shield, Michigan
9 Patient-centered Medical Home Case Study—Blue Cross Blue Shield PCMH Program in New Jersey
10 Evolution of New Organizations—Accountable Care Organization (ACO)
11 Fast Facts—3 Different Models for ACOs
12 Leading ACOs
13 Impact of ACOs on Clinical Laboratory Tests
14 Impact of ACOs on Clinical Laboratory Tests

Trend 2—Investing in Unifying Technologies
1 Competitors Remodel to Meet Needs
2 Reshuffling Models
3 Evidence of Reshuffling
4 Case Study—Roche

Trend 3—Consolidation and Automation of Labs
1 Factors Pushing Consolidation of Labs
2 Consolidation of Clinics Over the Years
3 Automation Case Study—Siemens and Palos Community Hospital
4 Case Study—Consolidation

Trend 4—Shift to Data Driven Healthcare
1 The Growing Digitalization Of Healthcare
2 Integration of Technology in Labs and Hospitals— Transforming Care With Data
3 Innovative Patient Models—Philips
4 Integrated Healthcare Case Study
5 Transformative Healthcare
6 Consumer Market Companies Enabling IVD

Trend 5—Consumer Lab Testing
1 The Beginning of “Disruptive” Technology in Lab Testing
2 Disruption of the IVD Industry
3 Comparison of Theranos and Medicare's Pricing Structure
4 Case Study—Theranos
5 Retailers Providing Consumer Centric Healthcare

Trend 6—Convergence of Health Care
1 Healthy Convergence—Pharmaceuticals, Diagnostics, and Medical Devices
2 Intra-convergence
3 Digital Health and Diagnostics Inter Convergence Model—Diabetes
4 Inter-convergence—Rise of Companion Diagnostics

Last Word
1 Recap—3 Big Predictions
2 Legal Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.